$FROGNeutralLow

Simon Frederic sold $386K of FROG

Simon Frederic sold 4,800 shares of JFrog Ltd (FROG) at $80.47 ($0.39M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

6/10
3/10
Low
Neutral
SEC Form 4 filed today (2026-06-03) covering a sale on 2026-06-01.
Neutral-to-slightly negative (insider selling), tempered by 10b5-1 pre-arrangement.

Insider selling disclosed on SEC Form 4; likely limited fundamental signal given pre-arranged 10b5-1, but can affect near-term sentiment.

Director Simon Frederic sold 4,800 JFrog shares for ~$386K via an open-market transaction under a 10b5-1 plan.

Low likelihood of a sustained price move; any reaction is likely modest and short-lived.

Background

The article is an SEC EDGAR Form 4 disclosure of an insider (director) open-market sale by Simon Frederic at JFrog Ltd.

Why it matters

Because the sale is under a pre-arranged Rule 10b5-1 plan, it is generally less informative about near-term fundamentals than unscheduled selling.

Market relevance

Traders may monitor for unusual insider activity, but this specific disclosure is unlikely to drive a major repricing absent other catalysts.

Market effects

Minimal; this is company-specific insider activity with no stated operational/financial catalyst.

None indicated.

None indicated.

Alternative perspectives

10b5-1 sales can be purely scheduled liquidity events and may not reflect bearish expectations.

The filing doesn’t specify reasons for sale; without follow-on buys or changes in guidance, trading impact should be treated as sentiment-only.

Key entities

  • JFrog Ltd

    Public company whose director insider sale is disclosed on Form 4.

  • Simon Frederic

    Director who sold 4,800 shares under a 10b5-1 plan.

Related articles

$FROGLow

JFrog (FROG) Stock Is Up, What You Need To Know

JFrog (FROG) shares rose about 3% in the afternoon after Bank of America raised its price target to $100 from $85 and kept a Buy rating, following the stock’s re-rating after JFrog’s Q1 results on May 7. The article notes other firms (Oppenheimer, Morgan Stanley, UBS) also lifted targets after Q1, with full-year guidance cited at $630 million (midpoint).